Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Pattern and Frequency of Seroreactivity to Routinely Used Serologic Tests in Early-Treated Infants With HIV.

Puthanakit T, Ananworanich J, Akapirat S, Pattanachaiwit S, Ubolyam S, Assawadarachai V, Sawangsinth P, Jupimai T, Anugulruengkitt S, Tawan M, Kosalaraksa P, Borkird T, Suntarattiwong P, Kanjanavanit S, de Souza MS.

J Acquir Immune Defic Syndr. 2020 Mar 1;83(3):260-266. doi: 10.1097/QAI.0000000000002254.

PMID:
31917751
2.

Machine learning classification of neurocognitive performance in children with perinatal HIV initiating de novo antiretroviral therapy.

Paul RH, Cho KS, Belden AC, Mellins CA, Malee KM, Robbins RN, Salminen LE, Kerr SJ, Adhikari B, Garcia-Egan PM, Sophonphan J, Aurpibul L, Thongpibul K, Kosalaraksa P, Kanjanavanit S, Ngampiyaskul C, Wongsawat J, Vonthanak S, Suwanlerk T, Valcour VG, Preston-Campbell RN, Bolzenious JD, Robb M, Ananworanich J, Puthanakit T; PREDICT Study Group.

AIDS. 2019 Dec 27. doi: 10.1097/QAD.0000000000002471. [Epub ahead of print]

PMID:
31895148
3.

Nonalcoholic fatty liver disease and hepatic fibrosis among perinatally HIV-monoinfected Asian adolescents receiving antiretroviral therapy.

Sudjaritruk T, Bunupuradah T, Aurpibul L, Kosalaraksa P, Kurniati N, Sophonphan J, Trinavarat P, Visrutaratna P, Srinakarin J, Chaijitraruch N, Puthanakit T; NAFLD Study Group.

PLoS One. 2019 Dec 19;14(12):e0226375. doi: 10.1371/journal.pone.0226375. eCollection 2019.

4.

Quadrivalent Influenza Vaccine Prevents Illness and Reduces Healthcare Utilization Across Diverse Geographic Regions During Five Influenza Seasons: A Randomized Clinical Trial.

Dbaibo G, Amanullah A, Claeys C, Izu A, Jain VK, Kosalaraksa P, Rivera L, Soni J, Yanni E, Zaman K, Acosta B, Ariza M, Arroba Basanta ML, Bavdekar A, Carmona A, Cousin L, Danier J, Diaz A, Diez-Domingo J, Dinleyici EC, Faust SN, Garcia-Sicilia J, Gomez-Go GD, Gonzales MLA, Hacimustafaoglu M, Hughes SM, Jackowska T, Kant S, Lucero M, Mares Bermudez J, Martinón-Torres F, Montellano M, Prymula R, Puthanakit T, Ruzkova R, Sadowska-Krawczenko I, Szymanski H, Ulied A, Woo W, Schuind A, Innis BL; Flu4VEC Study Group.

Pediatr Infect Dis J. 2020 Jan;39(1):e1-e10. doi: 10.1097/INF.0000000000002504.

5.

Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents.

Biswal S, Reynales H, Saez-Llorens X, Lopez P, Borja-Tabora C, Kosalaraksa P, Sirivichayakul C, Watanaveeradej V, Rivera L, Espinoza F, Fernando L, Dietze R, Luz K, Venâncio da Cunha R, Jimeno J, López-Medina E, Borkowski A, Brose M, Rauscher M, LeFevre I, Bizjajeva S, Bravo L, Wallace D; TIDES Study Group.

N Engl J Med. 2019 Nov 21;381(21):2009-2019. doi: 10.1056/NEJMoa1903869. Epub 2019 Nov 6.

PMID:
31693803
6.

Trajectory Analysis of Cognitive Outcomes in Children With Perinatal HIV.

Patel PB, Apornpong T, Puthanakit T, Thongpibul K, Kosalaraksa P, Hansudewechakul R, Kanjanavanit S, Ngampiyaskul C, Luesomboon W, Wongsawat J, Sun LP, Chettra K, Saphonn V, Mellins CA, Malee K, Spudich S, Ananworanich J, Kerr SJ, Paul R; PREDICT/Resilience Study Group.

Pediatr Infect Dis J. 2019 Oct;38(10):1038-1044. doi: 10.1097/INF.0000000000002427.

PMID:
31568142
7.

Emotional and behavioral resilience among children with perinatally acquired HIV in Thailand and Cambodia.

Malee KM, Kerr S, Paul R, Puthanakit T, Thongpibul K, Kosalaraksa P, Ounchanum P, Kanjanavanit S, Aurpibul L, Ngampiyaskul C, Luesomboon W, Wongsawat J, Vonthanak S, Ly PS, Chettra K, Suwanlerk T, Sophonphan J, Valcour V, Ananworanich J, Mellins CA; PREDICT Resilience study.

AIDS. 2019 Jun 1;33 Suppl 1:S17-S27. doi: 10.1097/QAD.0000000000002182.

PMID:
31397719
8.

Increased Risk of Executive Function and Emotional Behavioral Problems Among Virologically Well-Controlled Perinatally HIV-Infected Adolescents in Thailand and Cambodia.

Kerr SJ, Puthanakit T, Malee KM, Thongpibul K, Ly PS, Sophonphan J, Suwanlerk T, Kosalaraksa P, Ounchanum P, Aurpibul L, Kanjanavanit S, Ngampiyaskul C, Chettra K, Robbins R, Paul R, Ananworanich J, Mellins CA.

J Acquir Immune Defic Syndr. 2019 Nov 1;82(3):297-304. doi: 10.1097/QAI.0000000000002132.

PMID:
31335589
9.

Clinical Presentation of Influenza in Children 6 to 35 Months of Age: Findings From a Randomized Clinical Trial of Inactivated Quadrivalent Influenza Vaccine.

Danier J, Rivera L, Claeys C, Dbaibo G, Jain VK, Kosalaraksa P, Woo W, Yanni E, Zaman K, Acosta B, Amanullah A, Ariza M, Luisa Arroba Basanta M, Bavdekar A, Carmona A, Cousin L, Diaz A, Diez-Domingo J, Cagri Dinleyici E, Faust SN, Garcia-Sicilia J, Gomez-Go GD, Antionette Gonzales L, Hacimustafaoglu M, Hughes SM, Izu A, Jackowska T, Kant S, Lucero M, Mares Bermudez J, Martinón-Torres F, Montellano M, Prymula R, Puthanakit T, Ruzkova R, Sadowska-Krawczenko I, Soni J, Szymanski H, Ulied A, Schuind A, Innis BL; Flu4VEC Study Group.

Pediatr Infect Dis J. 2019 Aug;38(8):866-872. doi: 10.1097/INF.0000000000002387.

PMID:
31306399
10.

Determinants of Viral Resuppression or Persistent Virologic Failure After Initial Failure With Second-Line Antiretroviral Treatment Among Asian Children and Adolescents With HIV.

Teeraananchai S, Kerr SJ, Gandhi M, Do VC, Van Nguyen L, Tran DNH, Kosalaraksa P, Singtoroj T, Thammajaruk N, Jupimai T, Sohn AH; TASER Pediatrics Study.

J Pediatric Infect Dis Soc. 2019 May 24. pii: piz034. doi: 10.1093/jpids/piz034. [Epub ahead of print]

PMID:
31125411
11.

CHAMP+ Thailand: Pilot Randomized Control Trial of a Family-Based Psychosocial Intervention for Perinatally HIV-Infected Early Adolescents.

Nestadt DF, Saisaengjan C, McKay MM, Bunupuradah T, Pardo G, Lakhonpon S, Gopalan P, Leu CS, Petdachai W, Kosalaraksa P, Srirompotong U, Ananworanich J, Mellins CA.

AIDS Patient Care STDS. 2019 May;33(5):227-236. doi: 10.1089/apc.2019.0021.

PMID:
31067121
12.

Mapping abnormal subcortical neurodevelopment in a cohort of Thai children with HIV.

Wade BSC, Valcour VG, Puthanakit T, Saremi A, Gutman BA, Nir TM, Watson C, Aurpibul L, Kosalaraksa P, Ounchanum P, Kerr S, Dumrongpisutikul N, Visrutaratna P, Srinakarin J, Pothisri M, Narr KL, Thompson PM, Ananworanich J, Paul RH, Jahanshad N; PREDICT and Resilience Study Groups.

Neuroimage Clin. 2019;23:101810. doi: 10.1016/j.nicl.2019.101810. Epub 2019 Apr 2.

13.

Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons.

Claeys C, Zaman K, Dbaibo G, Li P, Izu A, Kosalaraksa P, Rivera L, Acosta B, Arroba Basanta ML, Aziz A, Cabanero MA, Chandrashekaran V, Corsaro B, Cousin L, Diaz A, Diez-Domingo J, Dinleyici EC, Faust SN, Friel D, Garcia-Sicilia J, Gomez-Go GD, Antoinette Gonzales ML, Hughes SM, Jackowska T, Kant S, Lucero M, Malvaux L, Mares Bermudez J, Martinon-Torres F, Miranda M, Montellano M, Peix Sambola MA, Prymula R, Puthanakit T, Ruzkova R, Sadowska-Krawczenko I, Salamanca de la Cueva I, Sokal E, Soni J, Szymanski H, Ulied A, Schuind A, Jain VK, Innis BL; Flu4VEC Study Group.

Lancet Child Adolesc Health. 2018 May;2(5):338-349. doi: 10.1016/S2352-4642(18)30062-2. Epub 2018 Mar 5.

PMID:
30169267
14.

Safety, efficacy, and pharmacokinetics of single-tablet elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed, HIV-infected children: a single-arm, open-label trial.

Natukunda E, Gaur AH, Kosalaraksa P, Batra J, Rakhmanina N, Porter D, Shao Y, Zhang H, Pikora C, Rhee MS.

Lancet Child Adolesc Health. 2017 Sep;1(1):27-34. doi: 10.1016/S2352-4642(17)30009-3. Epub 2017 Jun 29.

PMID:
30169223
15.

Persistence of hepatitis B immune memory until 9-10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP∼T vaccination at 2, 4 and 6 months.

Kosalaraksa P, Chokephaibulkit K, Benjaponpitak S, Pancharoen C, Chuenkitmongkol S, B'Chir S, Da Costa X, Vidor E.

Hum Vaccin Immunother. 2018 May 4;14(5):1257-1265. doi: 10.1080/21645515.2018.1426418. Epub 2018 Feb 21.

16.

Cognition, Emotional Health, and Immunological Markers in Children With Long-Term Nonprogressive HIV.

Paul R, Apornpong T, Prasitsuebsai W, Puthanakit T, Saphonn V, Aurpibul L, Kosalaraksa P, Kanjanavanit S, Luesomboon W, Ngampiyaskul C, Suwanlerk T, Chettra K, Shearer WT, Valcour V, Ananworanich J, Kerr S.

J Acquir Immune Defic Syndr. 2018 Apr 1;77(4):417-426. doi: 10.1097/QAI.0000000000001619.

17.

Structural Neuroimaging and Neuropsychologic Signatures in Children With Vertically Acquired HIV.

Paul R, Prasitsuebsai W, Jahanshad N, Puthanakit T, Thompson P, Aurpibul L, Hansudewechakul R, Kosalaraksa P, Kanjanavanit S, Ngampiyaskul C, Luesomboon W, Lerdlum S, Pothisri M, Visrutaratna P, Valcour V, Nir TM, Saremi A, Kerr S, Ananworanich J; Pediatric Randomized Early versus Deferred Initiation in Cambodia and Thailand (PREDICT) Study Group.

Pediatr Infect Dis J. 2018 Jul;37(7):662-668. doi: 10.1097/INF.0000000000001852.

18.

Strategies to improve the uptake of effective contraception in perinatally HIV-infected adolescents.

Landolt NK, Achalapong J, Kosalaraksa P, Petdachai W, Ngampiyaskul C, Kerr S, Boonyanurak P, Ananworanich J, Bunupuradah T.

J Virus Erad. 2017 Jul 1;3(3):152-156.

19.

Treatment Outcomes of Third-line Antiretroviral Regimens in HIV-infected Thai Adolescents.

Prasitsuebsai W, Sophonphan J, Chokephaibulkit K, Wongsawat J, Kanjanavanit S, Kosalaraksa P, Ngampiyakul C, Sangkla P, Hansudewechakul R, Kerr SJ, Puthanakit T, Ananworanich J; HIV-NAT 113 Study Group.

Pediatr Infect Dis J. 2017 Oct;36(10):967-972. doi: 10.1097/INF.0000000000001638.

PMID:
28520611
20.

Carbohydrate, lipid, bone and inflammatory markers in HIV-positive adolescents on antiretroviral therapy and hormonal contraception.

Kancheva Landolt N, Bunupuradah T, Achalapong J, Kosalaraksa P, Petdachai W, Ngampiyaskul C, Ubolyam S, Thammajaruk N, Kerr S, Ananworanich J.

J Virus Erad. 2017 Jan 1;3(1):56-60.

21.

HIV-infected children in the Asia-Pacific region with baseline severe anemia: antiretroviral therapy and outcomes.

Lumbiganon P, Kosalaraksa P, Bunupuradah T, Boettiger D, Saphonn V, Truong KH, Kurniati N, Hansudewechakul R, Do VC, Sudjaritruk T, Kumarasamy N, Kongstan N, Yusoff NK, Nguyen LV, Wati DK, Razali K, Sohn AH, Kariminia A.

Asian Biomed (Res Rev News). 2016 Jun;10(3):229-234.

22.

Long-term Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers and Booster Response 5 Years After Primary Immunization.

Kosalaraksa P, Watanaveeradej V, Pancharoen C, Capeding MR, Feroldi E, Bouckenooghe A.

Pediatr Infect Dis J. 2017 Apr;36(4):e108-e113. doi: 10.1097/INF.0000000000001494.

PMID:
28030526
23.

Response to Tenofovir Among Lamivudine-experienced Hepatitis B and HIV-coinfected Adolescents.

Aurpibul L, Lumbiganon P, Hansudewechakul R, Kanjanavanit S, Bunupuradah T, Kosalaraksa P, Taeprasert P, Puthanakit T.

Pediatr Infect Dis J. 2017 Apr;36(4):401-404. doi: 10.1097/INF.0000000000001491.

24.

Post-licensure, phase IV, safety study of a live attenuated Japanese encephalitis recombinant vaccine in children in Thailand.

Chotpitayasunondh T, Pruekprasert P, Puthanakit T, Pancharoen C, Tangsathapornpong A, Oberdorfer P, Kosalaraksa P, Prommalikit O, Tangkittithaworn S, Kerdpanich P, Techasaensiri C, Korejwo J, Chuenkitmongkol S, Houillon G.

Vaccine. 2017 Jan 5;35(2):299-304. doi: 10.1016/j.vaccine.2016.11.062. Epub 2016 Nov 28.

25.

Impact of tenofovir disoproxil fumarate on bone metabolism and bone mass among perinatally HIV-infected Asian adolescents.

Sudjaritruk T, Bunupuradah T, Aurpibul L, Kosalaraksa P, Kurniati N, Sophonphan J, Ananworanich J, Puthanakit T; Bone-D study group.

Antivir Ther. 2017;22(6):471-479. doi: 10.3851/IMP3103. Epub 2016 Oct 27.

PMID:
27786155
26.

Safety, efficacy, and pharmacokinetics of a single-tablet regimen containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in treatment-naive, HIV-infected adolescents: a single-arm, open-label trial.

Gaur AH, Kizito H, Prasitsueubsai W, Rakhmanina N, Rassool M, Chakraborty R, Batra J, Kosalaraksa P, Luesomboon W, Porter D, Shao Y, Myers M, Ting L, SenGupta D, Quirk E, Rhee MS.

Lancet HIV. 2016 Dec;3(12):e561-e568. doi: 10.1016/S2352-3018(16)30121-7. Epub 2016 Oct 17.

PMID:
27765666
27.

Therapeutic Drug Monitoring of Lopinavir in HIV-Infected Children on Second-Line Antiretroviral Therapy in Asia.

Aurpibul L, Teerananchai S, Prasitsuebsai W, Sudjaritruk T, Kosalaraksa P, Kurniati N, Truong KH, Do VC, Nguyen LV, Chokephaibulkit K, Singtoroj T, Kerr SJ.

Ther Drug Monit. 2016 Dec;38(6):791-795.

28.

Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression.

Sudjaritruk T, Bunupuradah T, Aurpibul L, Kosalaraksa P, Kurniati N, Prasitsuebsai W, Sophonphan J, Sohn AH, Ananworanich J, Puthanakit T; Bone-D Study Group.

HIV Med. 2017 Apr;18(4):235-244. doi: 10.1111/hiv.12418. Epub 2016 Aug 1.

29.

Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials.

Moreira ED Jr, Block SL, Ferris D, Giuliano AR, Iversen OE, Joura EA, Kosalaraksa P, Schilling A, Van Damme P, Bornstein J, Bosch FX, Pils S, Cuzick J, Garland SM, Huh W, Kjaer SK, Qi H, Hyatt D, Martin J, Moeller E, Ritter M, Baudin M, Luxembourg A.

Pediatrics. 2016 Aug;138(2). pii: e20154387. doi: 10.1542/peds.2015-4387. Epub 2016 Jul 15.

30.

Treatment Outcomes and Resistance Patterns of Children and Adolescents on Second-Line Antiretroviral Therapy in Asia.

Prasitsuebsai W, Teeraananchai S, Singtoroj T, Truong KH, Ananworanich J, Do VC, Nguyen LV, Kosalaraksa P, Kurniati N, Sudjaritruk T, Chokephaibulkit K, Kerr SJ, Sohn AH.

J Acquir Immune Defic Syndr. 2016 Aug 1;72(4):380-6. doi: 10.1097/QAI.0000000000000971.

31.

Low Risk of CD4 Decline After Immune Recovery in Human Immunodeficiency Virus-Infected Children With Viral Suppression.

Kosalaraksa P, Boettiger DC, Bunupuradah T, Hansudewechakul R, Saramony S, Do VC, Sudjaritruk T, Yusoff NKN, Razali KAM, Nguyen LV, Nallusamy R, Fong SM, Kurniati N, Truong KH, Sohn AH, Chokephaibulkit K; TREAT Asia Pediatric HIV Observational Database.

J Pediatric Infect Dis Soc. 2017 Jun 1;6(2):173-177. doi: 10.1093/jpids/piw031.

32.

High Variability of Hormonal Levels and No Clinically Relevant Interaction Between Ethinyl Estradiol, Desogestrel and Lopinavir/Ritonavir in a Small Sample of HIV-positive Adolescents.

Kancheva Landolt N, Bunupuradah T, Kosalaraksa P, Ubolyam S, Thammajaruk N, Cremers S, Zott R, Kerr S, Ananworanich J; HIV-NAT 176 study.

J Acquir Immune Defic Syndr. 2016 Aug 15;72(5):507-12. doi: 10.1097/QAI.0000000000000997.

PMID:
26990825
33.

Soluble CD163 and monocyte populations in response to antiretroviral therapy and in relationship with neuropsychological testing among HIV-infected children.

Ananworanich J, Kerr SJ, Jaimulwong T, Vibol U, Hansudewechakul R, Kosalaraksa P, Ngampiyaskul C, Kanjanavanit S, Wongsawat J, Luesomboon W, Apornpong T, Soulas C, Paul R, Ruxrungtham K, Puthanakit T.

J Virus Erad. 2015;1(3):196-202. Epub 2015 Jun 30.

34.

Hypovitaminosis D and hyperparathyroidism: effects on bone turnover and bone mineral density among perinatally HIV-infected adolescents.

Sudjaritruk T, Bunupuradah T, Aurpibul L, Kosalaraksa P, Kurniati N, Prasitsuebsai W, Sophonphan J, Ananworanich J, Puthanakit T; Bone-D Study Group.

AIDS. 2016 Apr 24;30(7):1059-67. doi: 10.1097/QAD.0000000000001032.

PMID:
26807972
35.

Using Lopinavir Concentrations in Hair Samples to Assess Treatment Outcomes on Second-Line Regimens Among Asian Children.

Prasitsuebsai W, Kerr SJ, Truong KH, Ananworanich J, Do VC, Nguyen LV, Kurniati N, Kosalaraksa P, Sudjaritruk T, Chokephaibulkit K, Thammajaruk N, Singtoroj T, Teeraananchai S, Horng H, Bacchetti P, Gandhi M, Sohn AH.

AIDS Res Hum Retroviruses. 2015 Oct;31(10):1009-14. doi: 10.1089/AID.2015.0111. Epub 2015 Aug 26.

36.

Premenstrual Disorders Among Perinatally HIV-Infected Adolescents.

Kancheva Landolt N, Bunupuradah T, Achalapong J, Kosalaraksa P, Petdachai W, Ngampiyaskul C, Auchieng C, Ananworanich J, Boonyanurak P.

J Acquir Immune Defic Syndr. 2015 Dec 1;70(4):e150-3. doi: 10.1097/QAI.0000000000000762. No abstract available.

PMID:
26181814
37.

An open-label, randomized study of a 9-valent human papillomavirus vaccine given concomitantly with diphtheria, tetanus, pertussis and poliomyelitis vaccines to healthy adolescents 11-15 years of age.

Kosalaraksa P, Mehlsen J, Vesikari T, Forstén A, Helm K, Van Damme P, Joura EA, Ciprero K, Maansson R, Luxembourg A, Sobanjo-ter Meulen A.

Pediatr Infect Dis J. 2015 Jun;34(6):627-34. doi: 10.1097/INF.0000000000000694.

PMID:
25831420
38.

HLA-DRB1454 and predictors of new-onset asthma in HIV-infected Thai children.

Bunupuradah T, Hansudewechakul R, Kosalaraksa P, Ngampiyaskul C, Kanjanavanit S, Wongsawat J, Luesomboon W, Sophonphan J, Puthanakit T, Ruxrungtham K, Shearer WT, Ananworanich J; PREDICT study group.

Clin Immunol. 2015 Mar;157(1):26-9. doi: 10.1016/j.clim.2014.12.006. Epub 2014 Dec 26. No abstract available.

PMID:
25546395
39.

Immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine as a booster dose in 12- to 18-month-old children primed with 3 doses of 7-valent pneumococcal conjugate vaccine.

Thisyakorn U, Chokephaibulkit K, Kosalaraksa P, Benjaponpitak S, Pancharoen C, Chuenkitmongkol S.

Hum Vaccin Immunother. 2014;10(7):1859-65. doi: 10.4161/hv.28642.

40.

AS03B-adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo-controlled, observer-blinded trial.

Kosalaraksa P, Jeanfreau R, Frenette L, Drame M, Madariaga M, Innis BL, Godeaux O, Izurieta P, Vaughn DW.

J Infect Dis. 2015 Mar 1;211(5):801-10. doi: 10.1093/infdis/jiu548. Epub 2014 Oct 6.

41.

What can volunteer co-providers contribute to health systems? The role of people living with HIV in the Thai paediatric HIV programme.

Tulloch O, Taegtmeyer M, Ananworanich J, Chasombat S, Kosalaraksa P, Theobald S.

Soc Sci Med. 2015 Nov;145:184-92. doi: 10.1016/j.socscimed.2014.09.017. Epub 2014 Sep 10.

PMID:
25239008
42.

Switching from efavirenz to nevirapine in children: 1-week dose escalation strategy.

Udomphanit T, Lumbiganon P, Rattanamanee S, Harnlakorn P, Sopharak C, Sringam J, Anutchatchaval S, Tharnprisan P, Kosalaraksa P.

AIDS Res Hum Retroviruses. 2014 Aug;30(8):727-9. doi: 10.1089/aid.2013.0257. Epub 2014 Jun 12. No abstract available.

PMID:
24921980
43.

Comparison of adherence monitoring tools and correlation to virologic failure in a pediatric HIV clinical trial.

Intasan J, Bunupuradah T, Vonthanak S, Kosalaraksa P, Hansudewechakul R, Kanjanavanit S, Ngampiyaskul C, Wongsawat J, Luesomboon W, Apornpong T, Kerr S, Ananworanich J, Puthanakit T; PREDICT Study Group.

AIDS Patient Care STDS. 2014 Jun;28(6):296-302. doi: 10.1089/apc.2013.0276.

44.

From transmission to transition: lessons learnt from the Thai paediatric antiretroviral programme.

Tulloch O, Theobald S, Ananworanich J, Chasombat S, Kosalaraksa P, Jirawattanapisal T, Lakonphon S, Lumbiganon P, Taegtmeyer M.

PLoS One. 2014 Jun 3;9(6):e99061. doi: 10.1371/journal.pone.0099061. eCollection 2014.

45.

Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV.

Kerr SJ, Puthanakit T, Vibol U, Aurpibul L, Vonthanak S, Kosalaraksa P, Kanjanavanit S, Hansudewechakul R, Wongsawat J, Luesomboon W, Ratanadilok K, Prasitsuebsai W, Pruksakaew K, van der Lugt J, Paul R, Ananworanich J, Valcour V; SEARCH 012 Study Team.

AIDS Care. 2014;26(11):1327-35. doi: 10.1080/09540121.2014.920949. Epub 2014 May 30.

46.

Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: a randomized study of immunogenicity and safety.

Feroldi E, Pancharoen C, Kosalaraksa P, Chokephaibulkit K, Boaz M, Meric C, Hutagalung Y, Bouckenooghe A.

Pediatr Infect Dis J. 2014 Jun;33(6):643-9. doi: 10.1097/INF.0000000000000276.

PMID:
24717964
47.

Association between lymphocyte and monocyte subsets and cognition in children with HIV.

Ananworanich J, Bunupuradah T, Apornpong T, Kosalaraksa P, Hansudewechakul R, Kanjanavanit S, Ngampiyaskul C, Wongsawat J, Luesomboon W, Ngo-Giang-Huong N, Jaimulwong T, Kerr SJ, Brouwers P, Shearer WT, Puthanakit T; PREDICT Study Group.

AIDS Res Ther. 2014 Jan 22;11(1):7. doi: 10.1186/1742-6405-11-7.

48.

Uncommon clinical presentations of melioidosis in children: 2 cases with sore throat and 1 case with urticarial rash.

Lumbiganon P, Kosalaraksa P.

Southeast Asian J Trop Med Public Health. 2013 Sep;44(5):862-5.

PMID:
24437321
49.

Simplifying antiretroviral therapy to lopinavir/ritonavir monotherapy did not improve quality of life and therapy adherence in pretreated HIV-infected children.

Bunupuradah T, Panthong A, Kosalaraksa P, Wongsabut J, Puthanakit T, Lumbiganon P, Chuanjaroen T, Sopharak C, Udompanit T, Prasitsuebsai W, Pancharoen C, Ananworanich J; HIV-NAT 077 Study Team.

AIDS Res Hum Retroviruses. 2014 Mar;30(3):260-5. doi: 10.1089/AID.2013.0204. Epub 2013 Dec 21.

PMID:
24274723
50.

Impact of antiretroviral therapy on quality of life in HIV-infected Southeast Asian children in the PREDICT study.

Bunupuradah T, Kosalaraksa P, Vibol U, Hansudewechakul R, Sophonphan J, Kanjanavanit S, Ngampiyaskul C, Wongsawat J, Luesomboon W, Vonthanak S, Ananworanich J, Ruxrungtham K, Puthanakit T; Predict Study Group.

AIDS Patient Care STDS. 2013 Nov;27(11):596-603. doi: 10.1089/apc.2013.0203.

Supplemental Content

Loading ...
Support Center